Russell Investments Group
VRTX icon

Russell Investments Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Russell Investments Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$168M Sell
336,990
-30,701
-8% -$13.6M 0.15% 122
2026
Q1 		$164M Sell
367,691
-13,771
-4% -$6.42M 0.18% 108
2025
Q4 		$173M Buy
381,462
+40,414
+12% +$17.4M 0.19% 95
2025
Q3 		$134M Buy
341,048
+27,326
+9% +$11.4M 0.15% 131
2025
Q2 		$140M Sell
313,722
-23,725
-7% -$10.9M 0.18% 113
2025
Q1 		$164M Buy
337,447
+98,105
+41% +$45.7M 0.22% 79
2024
Q4 		$96.3M Buy
239,342
+9,377
+4% +$4.35M 0.13% 154
2024
Q3 		$107M Sell
229,965
-31,186
-12% -$15M 0.15% 139
2024
Q2 		$122M Sell
261,151
-15,366
-6% -$6.67M 0.2% 94
2024
Q1 		$116M Sell
276,517
-14,733
-5% -$6.23M 0.18% 117
2023
Q4 		$119M Sell
291,250
-65,369
-18% -$24.1M 0.21% 94
2023
Q3 		$124M Sell
356,619
-4,464
-1% -$1.56M 0.25% 74
2023
Q2 		$127M Sell
361,083
-24,650
-6% -$8.31M 0.25% 74
2023
Q1 		$121M Buy
385,733
+16,228
+4% +$4.87M 0.24% 83
2022
Q4 		$107M Buy
369,505
+45,393
+14% +$13.8M 0.22% 93
2022
Q3 		$94M Buy
324,112
+21,966
+7% +$6.32M 0.21% 101
2022
Q2 		$85M Sell
302,146
-36,736
-11% -$9.83M 0.17% 131
2022
Q1 		$88.1M Buy
338,882
+36,521
+12% +$8.67M 0.15% 161
2021
Q4 		$66.5M Buy
302,361
+2,729
+0.9% +$531K 0.11% 221
2021
Q3 		$54.4M Sell
299,632
-45,095
-13% -$8.8M 0.09% 259
2021
Q2 		$69.4M Buy
344,727
+149,285
+76% +$31.2M 0.12% 193
2021
Q1 		$41.9M Sell
195,442
-52,367
-21% -$11.5M 0.07% 322
2020
Q4 		$58.3M Sell
247,809
-8,491
-3% -$1.95M 0.12% 198
2020
Q3 		$69.6M Sell
256,300
-2,808
-1% -$775K 0.15% 148
2020
Q2 		$74.9M Buy
259,108
+84,554
+48% +$22.9M 0.17% 128
2020
Q1 		$41.3M Buy
174,554
+71,011
+69% +$16.3M 0.11% 219
2019
Q4 		$22.7M Buy
103,543
+48,437
+88% +$9.8M 0.04% 497
2019
Q3 		$9.27M Sell
55,106
-112,128
-67% -$19.8M 0.02% 891
2019
Q2 		$30.5M Sell
167,234
-56,984
-25% -$9.96M 0.06% 398
2019
Q1 		$41.2M Sell
224,218
-6,142
-3% -$1.13M 0.08% 314
2018
Q4 		$37.9M Sell
230,360
-4,722
-2% -$818K 0.08% 267
2018
Q3 		$45.2M Buy
235,082
+108,446
+86% +$19.3M 0.09% 248
2018
Q2 		$20.8M Sell
126,636
-32,675
-21% -$5.06M 0.04% 517
2018
Q1 		$25.9M Buy
159,311
+32,557
+26% +$5.32M 0.04% 488
2017
Q4 		$19.2M Buy
126,754
+5,721
+5% +$847K 0.03% 668
2017
Q3 		$18.4M Sell
121,033
-83,864
-41% -$12.6M 0.03% 673
2017
Q2 		$26.4M Buy
204,897
+107,975
+111% +$13M 0.05% 490
2017
Q1 		$10.6M Buy
96,922
+23,528
+32% +$2.07M 0.02% 842
2016
Q4 		$5.46M Buy
+73,394
New +$5.97M 0.01% 1189

Other funds holding VRTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Russell Investments Group's VRTX Position: Q2 2026 in Review

Russell Investments Group reduced its Vertex Pharmaceuticals (VRTX) stake by 8.3% in Q2 2026, selling an estimated $13.6M and leaving 336,990 shares worth $168M. The position accounts for 0.15% of the portfolio, ranked #122.

Russell Investments Group first reported a position in VRTX in Q4 2016 and has held it in 39 quarters since. The position peaked at $173M in Q4 2025. 1,014 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Russell Investments Group held 336,990 shares of Vertex Pharmaceuticals worth $168M as of Q2 2026.
  • Russell Investments Group sold 30,701 Vertex Pharmaceuticals shares in Q2 2026, an estimated $13.6M.
  • Vertex Pharmaceuticals made up 0.15% of Russell Investments Group's portfolio in Q2 2026, its #122 holding.
  • Russell Investments Group first reported a position in Vertex Pharmaceuticals in Q4 2016 and has held it in 39 quarters since.
  • Russell Investments Group's Vertex Pharmaceuticals position peaked at $173M in Q4 2025.
  • 1,014 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.